Reneo Pharmaceuticals News

Reneo Pharmaceuticals | 10-K/A: Annual report (Amendment)

Apr 26 06:18 ET

Reneo Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 28 16:10 ET

Reneo Pharmaceuticals | 8-K: Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

Mar 28 16:08 ET

Reneo Pharmaceuticals | 10-K: Annual report

Mar 28 16:07 ET

Reneo Pharmaceuticals | 8-K: Current report

Feb 23 16:05 ET

Reneo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-OCTAGON CAPITAL ADVISORS LP(6.75%),OCTAGON INVESTMENTS MASTER FUND LP(6.75%), etc.

Feb 5 16:05 ET

Reneo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Braden M Leonard(5.1%),BML Investment Partners, L.P.(4.1%)

Jan 17 00:00 ET

Reneo Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(9.996%),TANG CAPITAL MANAGEMENT, LLC(9.996%), etc.

Dec 26, 2023 00:00 ET

Reneo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(0%)

Dec 15, 2023 16:55 ET

Reneo Pharmaceuticals | 8-K: Current report

Dec 14, 2023 09:26 ET

Reneo Pharmaceuticals | EFFECT: Others

Nov 22, 2023 00:15 ET

Reneo Pharmaceuticals | CORRESP: CORRESP

Nov 17, 2023 16:05 ET

Reneo Pharmaceuticals | UPLOAD: Others

Nov 16, 2023 14:36 ET

Reneo Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Nov 13, 2023 17:08 ET

Reneo Pharmaceuticals | 424B5: Prospectus

Nov 13, 2023 16:58 ET

Reneo Pharmaceuticals: Q3 2023 Earnings Report

Nov 13, 2023 16:05 ET

Reneo Pharmaceuticals | 8-K: Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 13, 2023 16:00 ET

Reneo Pharmaceuticals | 8-K: Current report

Oct 30, 2023 16:47 ET

Reneo Pharmaceuticals | 8-K: Current report

Oct 10, 2023 06:08 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hall Ashley

Aug 29, 2023 17:04 ET